中文 | English
Return
Total: 261 , 1/27
Show Home Prev Next End page: GO
Author:(Lin KUI)

1.Analysis of notifiable infectious diseases in Zhejiang Province in 2024

DING Zheyuan ; YANG Yan ; FU Tianying ; LU Qinbao ; WANG Xinyi ; WU Haocheng ; LIU Kui ; LIN Junfen ; WU Chen

Journal of Preventive Medicine 2025;37(5):433-438,442

2.A new triterpenoid from Elephantopus scaber.

Zu-Xiao DING ; Hong-Xi XIE ; Lin CHEN ; Jun-Jie HAO ; Yan-Qiu LUO ; Zhi-Yong JIANG ; Shi-Kui XU

China Journal of Chinese Materia Medica 2025;50(5):1224-1230

3.Color-component correlation and mechanism of component transformation of processed Citri Reticulatae Semen.

Kui-Lin ZHU ; Jin-Lian ZOU ; Xu-Li DENG ; Mao-Xin DENG ; Hai-Ming WANG ; Rui YIN ; Zhang-Xian CHEN ; Yun-Tao ZHANG ; Hong-Ping HE ; Fa-Wu DONG

China Journal of Chinese Materia Medica 2025;50(9):2382-2390

4.Studies on common irritant components in three different base sources of Polygonati Rhizoma.

Yu-Xin GU ; Hong-Li YU ; Min SHEN ; Xin-Zhi WANG ; Kui-Long WANG ; Jie CAO ; Qian-Lin CHEN ; Yan-Qing XU ; Chang-Li SHEN ; Hao WU

China Journal of Chinese Materia Medica 2025;50(12):3223-3231

5.Prodrug-based combinational nanomedicine remodels lipid metabolism for reinforced ferroptosis and immune activation.

Ling LIN ; Zaixiang FANG ; Guohao LIU ; Yiwei LIU ; Zhiqian LI ; Dayi PAN ; Yunkun LI ; Hemi KANG ; Xiaoding SHEN ; Jingyao ZHANG ; Qiyong GONG ; Kui LUO ; Jing JING

Acta Pharmaceutica Sinica B 2025;15(5):2746-2763

6.Marine-derived new peptaibols with antibacterial activities by targeting bacterial membrane phospholipids.

Shang CHEN ; Dong LIU ; Liyang WANG ; Aili FAN ; Mengyue WU ; Ning XU ; Kui ZHU ; Wenhan LIN

Acta Pharmaceutica Sinica B 2025;15(5):2764-2777

7.Polyfoliate anterolateral thigh perforator flap in reconstruction of large soft tissue defects around ankle: a study on 11 cases

Tao LIANG ; Jinming TANG ; Junhua PAN ; Zunwen LIN ; Rong YUAN ; Kui DENG ; Gendong HUANG ; Huizhi DENG

Chinese Journal of Microsurgery 2024;47(1):22-27

8.Effects of Fuke Qianjin Formula and its modifications on the sequelae of pelvic inflammatory disease in rats

Jia XU ; Ya-Li TAN ; Zhi-Kui XIAO ; Ji-Lin KUANG ; Li-Mei LIN ; Lei LEI

Chinese Traditional Patent Medicine 2024;46(8):2571-2579

9.Clinical trial of rivaroxaban in the treatment of anticoagulation in patients with pulmonary embolism during maintenance period

Hui QIAN ; Kui LIU ; Ya-Lin JIANG ; Xia ZHAO

The Chinese Journal of Clinical Pharmacology 2024;40(7):959-962

10.Effects and mechanism of rhubarb Tangluo pill on liver injury in type 2 diabetic rats

Dong AN ; Yong-Lin LIANG ; Yan-Kui GAO ; Feng-Zhe YAN ; Min BAI ; Si-Chen ZHAO ; Zhong-Tang LIU ; Xiao NIE

The Chinese Journal of Clinical Pharmacology 2024;40(9):1282-1286

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 261 , 1/27 Show Home Prev Next End page: GO